{"name":"Becton, Dickinson and Company","slug":"becton-dickinson","ticker":"BDX","exchange":"NYSE","domain":"bd.com","description":"Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.","hq":"Franklin Lakes, NJ","founded":0,"employees":"70000","ceo":"Tom Polen","sector":"MedTech","stockPrice":156.94,"stockChange":1.98,"stockChangePercent":1.28,"marketCap":"$56.9B","metrics":{"revenue":21840000000,"revenueGrowth":1.6,"grossMargin":46.8,"rdSpend":1265000000,"netIncome":1678000000,"cash":641000000,"dividendYield":2.71,"peRatio":25.6,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"BDX Reports Fourth-Quarter and Full-Year 2023 Results","summary":"Becton, Dickinson and Company (BDX) reported its fourth-quarter and full-year 2023 results, with revenue of $14.8 billion and adjusted earnings per share of $4.63.","drugName":"","sentiment":"neutral"},{"date":"2023-09-01","type":"deal","headline":"BDX Acquires C.R. Bard for $24 Billion","summary":"Becton, Dickinson and Company (BDX) acquired C.R. Bard for $24 billion, expanding its presence in the medical technology sector.","drugName":"","sentiment":"positive"},{"date":"2022-06-01","type":"regulatory","headline":"FDA Approves BD's Alaris System","summary":"The U.S. Food and Drug Administration (FDA) approved Becton, Dickinson and Company's (BDX) Alaris system, a medical device used for infusion therapy.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-04-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNYkgzU1gyMU5IdjJmUy1Ha3ItR0dFa21fZG5IcUtwdzUzVVhGczN0djY3RzF2a2lCMmxpOWRIb0xmRGJBS3hrWVNPckVxOXdYM0luVHV0d29ETGRYU2FnSXBib0YwWVNsNjNTRXFmeXYwd3lMQ0h3U2Y0QW1COTlZOGtpZ0NudUFodGtOOTI2dUlKdjhDMTQ2c2hDUlU2ZGNtUFE5S0lyQ0pWWWdjamJ3SUM3cnFNa2ptWExKSkJjdjBzcWI0cWxTWV9n?oc=5","date":"2026-03-11","type":"pipeline","source":"BD Newsroom","summary":"BD and Sinteco Advance Healthcare Workflows, Improving Patient Safety in Medication Delivery and Handling - BD Newsroom","headline":"BD and Sinteco Advance Healthcare Workflows, Improving Patient Safety in Medication Delivery and Handling","sentiment":"neutral"},{"date":"2026-02-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-09","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOMm1nNk9aa3NWUjNveHh4V1AtZ0JTd1B2R1dJN1ZjQkpuc21OamkwMDc0dHNlUF9KcDNJdWVBZE9uRUhKejVoeFN2aVhxWGNadDZsUGpQZDdwUGdfRTVRMkY4RlU4cG9YbHdPbUFpOVQ5NzBlQ3ZCUks0aXgwcm14cWljN3hkYVVOVmQzSXlBUVY1Mm5rei03WjdkZWVvZ2psOHdpa3p3NmxudzZndl9RcGZNaU5FaEpxeTRPcXEwdUpoUEpYdDlyZTU4VGYyUQ?oc=5","date":"2026-01-21","type":"deal","source":"PR Newswire","summary":"BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market - PR Newswire","headline":"BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQXJncUVicTBFem9mR2V1aVdidDNOaUhFUUdKSDR2aDd2aEJpY0tIRWFyMzZXTzhQc21adF9FRjZiUjVnVE03dlBQQmV0WmRwYkpJY1B4eXpEbmVta0wwNkRfTFVyUHJ6RWNYUnFfcTZzcDlpTURjZGlmR0o4NHV6bFhEUjVwaTZseUQ0UlY1OFlrajBOd0REMUdVdE1TbDVjVkdaNkZkZTFTZXI0dUZTMTFlVy1GWnVV?oc=5","date":"2026-01-13","type":"pipeline","source":"BD Newsroom","summary":"BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs - BD Newsroom","headline":"BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOeVFYODktdXJxQmIzaEphVmJVb0t1ckVhcHZoZVNEa3JSQURaSEsyQ1NickpNWWw0U0pzc0VrRGJDd0diSkNRQUV1YkV0OWJnTlZiaEFwd1pQZUVOV0hDV2ViT0tzX2FFU1dhNHZDUXd3LXBnR1dpbjcwbGdxWjl2Y0NTUkRQeHFNZlJfU0FEV3c0WGc4Yjhnd25mTGMtVHQwX05kUlNUYTV1RzZjY1hhdjBHLXU5Tnhqc19BcHhB?oc=5","date":"2026-01-13","type":"pipeline","source":"Stock Titan","summary":"Nebraska plant gets $110M boost to make syringes for new biologic drugs - Stock Titan","headline":"Nebraska plant gets $110M boost to make syringes for new biologic drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOa3loeGVFVWEwQXBxRnVHSWpTSXNXTkZfSGdCOG9kZ0pkSWFKODNZZzhTQ1JyQ1JabUx2ckdVTmpVS2c4VFdOX09lakNlRjZWaTZBaWN2SU1ZcE1YS2l1bFdQQnZiUUlsb1dmNmlKNk9wWFhnSWFjQ0w5Zk1TaXRNSmxlR3U1WjFNVUZlbm02aVNrWmRFRmdKWExPc05oWWFINW5LTTltV28zc1dWdElTQVdaTjRxWWlOZVlBSA?oc=5","date":"2025-11-06","type":"earnings","source":"TradingView","summary":"BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up - TradingView","headline":"BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9GcVlrYTY1WkU2Vl85dkdRWHpBMkhKVWhFTGpjUUxzeHRaN3VRRVJOTFFEa1hXVVA3SlZXXzlwS0dHM09qdVl6cUh3RGVadENNZGJteHdPMmZMd1FXeHJyWldmUC1OdVdsRVJOcVJVcERhcG9nY1dtb1Zn?oc=5","date":"2025-10-01","type":"pipeline","source":"Yahoo Finance","summary":"BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience - Yahoo Finance","headline":"BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQQ1N6Zng5akl2UDVnSUlhdFU3Z2F3YmhqYVh6ellRam05R1piTm1wQW1hR0J5UE5PV2RuVGtRUXpQb1lhVUZsdHFmNEMwUXVwX3lLekptUUF0RzM4WEVFWDlqemVVdDVKcm92QVFTa1FERm1QbGJWem5oNjFnRkxNQlcwa2NFWUJLUnFYdlVDcDF1NnVFZUtSeHNDQ2NnTDBRa1FGaDhYakowRlBKT1JLOEVtUnh1U0l0bV9LanYzTHpjVkZ4MHhzaFl3SGVJbzF0VXNYWVJ2Nk9fZmowTVcyZFlsWVhuMU5yUlFPQmpfVDRWWmtQQzZ3c2xaZThhdHplbThYRzFvN0NxQmc?oc=5","date":"2025-09-22","type":"deal","source":"PR Newswire","summary":"BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery - PR Newswire","headline":"BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Deliv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOOG5iY3pMS3dXel9MdjRWZE9hbjdzR0JENmFwN3lRVVVEdjZJUk9aaUQ3RVZaVTZqNThVdDlXanZRcDJjSFZOWGx1RFZLUGVjWEI3YTk0eW9meUxJYm5Oek9CczMzem5fZ2hGRTZqRGExYkR4WDl0OFVhemF4UE5zTGZ3NUlBVVlYN3BHNTYwaW1EN1FfVTFoZlBXdl84eUM2cThZcWR3N2FlZXg5ZTRxelZraFRIY2FscFMyVkZROENkTTJXbUdBblhmNXBGMTB6bmVDWGhCUVZCcXZ5TURFbDVKMzEzLTkxQ2R6TzB1dWVMeHhRQklDc29PN3VwWHplNkE?oc=5","date":"2025-07-23","type":"trial","source":"PR Newswire","summary":"BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - PR Newswire","headline":"BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxPeEJiN3kxWkpRU21zWWxVbHF2eUdTS1JIV1ZnMGpJZ0dfeEhxZEFtMXloSG1wcVFvVVd2cjJCc3BwbjZmVS1YUGRHeGJsR2x2aFQ5YWVhcjl4ZFJyaHdGdXlGS2VWdHRMZ0NKZzFCU2h6a2V3bnpPZmVTRTB1YmNTTFZadjM0d2VwQlNBX3hNcG9RUzNWXzVhVDRPTU1fVDA2OWVGZmJwYUM1NDl3OU14WGVFUjdPVFRFZVhDTVFiVnZBaldxU0NQZ3FZdkRYRmg5d0F0UnM0UzltVzFyM0dkY1JDWk9iQjItRHhaUDViZ2hOZDR2eDNxNGhLYzlCeGtYZ0dqQ3hLajJEWFQ1aWtVTHlyV25JSFhTZ20wY0FXTWhVVFU2SWFFRXRIQjN4aW9CSHRTaWNXVy1MeC05VF9z?oc=5","date":"2025-07-14","type":"pipeline","source":"investors.bd.com","summary":"Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing - investors.bd.com","headline":"Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader F","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-08","type":"pipeline","source":"CNBC","summary":"Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit - CNBC","headline":"Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNSnI4ejNwdTNBaE1oc3ROREN2dHhmZ3c3VHRFNnczRmlyeWdSd2lKejFBSVZxbzZWWG01NWxlLTRYSE5qZUJIOHN1QlVSSUhoV3hGM2ExOHZMdnIxajlNdHZBX0tJUVU3Qk9vbVVlWjZpdUZIaGEzYTZ6S3drUzRvVDZkcVVyT0VPYlE?oc=5","date":"2024-11-07","type":"earnings","source":"Yahoo Finance","summary":"Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth - Yahoo Finance","headline":"Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Or","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Abbott Laboratories (ABT)","Stryker Corporation (SYK)","Medtronic plc (MDT)"],"therapeuticFocus":["Diabetes Care","Oncology","Infectious Disease"],"financials":{"source":"sec_edgar","revenue":21840000000,"revenuePeriod":"2025-09-30","revenueHistory":[{"value":21840000000,"period":"2025-09-30"},{"value":20178000000,"period":"2024-09-30"},{"value":19372000000,"period":"2023-09-30"},{"value":18870000000,"period":"2022-09-30"},{"value":20248000000,"period":"2021-09-30"},{"value":17117000000,"period":"2020-09-30"}],"grossProfit":7577000000,"grossProfitHistory":[],"rdSpend":1265000000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":1678000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":641000000,"cashHistory":[],"totalAssets":55325000000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":156.94,"previousClose":154.96,"fiftyTwoWeekHigh":187.35,"fiftyTwoWeekLow":127.59,"fiftyTwoWeekRange":"127.58648 - 187.35","fiftyDayAverage":165.74,"twoHundredDayAverage":152.62,"beta":0.35,"enterpriseValue":62911590400,"forwardPE":11.6,"priceToBook":1.77,"priceToSales":2.59,"enterpriseToRevenue":2.87,"enterpriseToEbitda":10.41,"pegRatio":1.2,"ebitda":6041999872,"ebitdaMargin":27.6,"freeCashflow":3105250048,"operatingCashflow":3393999872,"totalDebt":19538999296,"debtToEquity":77.3,"currentRatio":1.05,"returnOnAssets":4.1,"returnOnEquity":7,"analystRating":"2.4 - Buy","recommendationKey":"buy","numberOfAnalysts":12,"targetMeanPrice":196.08,"targetHighPrice":225,"targetLowPrice":157,"dividendRate":4.2,"payoutRatio":0.68,"fiveYearAvgDividendYield":1.61,"exDividendDate":1773100800,"insiderHeldPercent":0.4,"institutionHeldPercent":96.3,"sharesOutstanding":284466650,"floatShares":283990091,"sharesShort":11469470,"shortRatio":4.18,"shortPercentOfFloat":4,"epsTrailing":6.12,"epsForward":13.51,"revenuePerShare":76.48,"bookValue":88.79,"officers":[{"age":52,"name":"Mr. Thomas E. Polen Jr.","title":"President, CEO & Chairman"},{"age":56,"name":"Mr. Michael  Garrison","title":"Executive VP & President of Medical Segment and BioPharma Systems Segments"},{"age":58,"name":"Mr. Richard E. Byrd","title":"Executive VP & President of Interventional Segment"},{"age":45,"name":"Mr. Michael C. Feld","title":"Executive VP, Chief Revenue Officer & President of Life Sciences Segmen"},{"age":42,"name":"Mr. Vitor  Roque","title":"Senior VP of Business Finance & Interim CFO"},{"age":48,"name":"Ms. Pamela L. Spikner","title":"Senior VP, Chief Accounting Officer & Controller"},{"age":48,"name":"Ms. Elizabeth  McCombs","title":"Executive VP & CTO"},{"age":null,"name":"Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.","title":"Senior VP & Chief Scientific Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://www.bd.com/investors/","website":"https://www.bd.com","phone":"201 847 6800"}}